chlorhexidine + lidocaine (Pharmedic)

Orafar is a combination antiseptic and local anesthetic product developed and marketed by Pharmedic. It contains chlorhexidine gluconate, a biguanide antiseptic with broad-spectrum antimicrobial activity, and lidocaine hydrochloride, an amide-type local anesthetic. The product is designed for the local treatment of infections and inflammatory conditions of the oral cavity and pharynx, such as sore throat, gingivitis, and mouth ulcers. Chlorhexidine acts by disrupting microbial cell membranes, while lidocaine provides rapid pain relief by blocking voltage-gated sodium channels. Orafar is available in dosage forms including lozenges and sprays for topical application to the oral mucosa.

Brand names

Orafar

Other names

chlorhexidine gluconate + lidocaine hydrochloride